nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cost density analysis of benign prostatic hyperplasia
|
Lanes, Stephan F. |
|
1996 |
18 |
5 |
p. 993-1004 12 p. |
artikel |
2 |
A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx®) versus intravenous phenytoin (Dilantin®) in hospital emergency departments
|
Marchetti, Albert |
|
1996 |
18 |
5 |
p. 953-966 14 p. |
artikel |
3 |
A retrospective assessment of cost avoidance associated with the use of nedocromil sodium metered-dose inhaler in the treatment of patients with asthma
|
Thomas, Peter |
|
1996 |
18 |
5 |
p. 939-952 14 p. |
artikel |
4 |
A review of health-related quality-of-life measures used in end-stage renal disease
|
Edgell, Eric T. |
|
1996 |
18 |
5 |
p. 887-938 52 p. |
artikel |
5 |
Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis
|
Chervinsky, Paul |
|
1996 |
18 |
5 |
p. 790-796 7 p. |
artikel |
6 |
Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media
|
Blumer, Jeffrey L. |
|
1996 |
18 |
5 |
p. 811-820 10 p. |
artikel |
7 |
Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life
|
Laibovitz, Robert |
|
1996 |
18 |
5 |
p. 821-832 12 p. |
artikel |
8 |
Editorial comment
|
Krosnick, Arthur |
|
1996 |
18 |
5 |
p. 789- 1 p. |
artikel |
9 |
Editorial comment
|
McGhan, WilliamF. |
|
1996 |
18 |
5 |
p. 968- 1 p. |
artikel |
10 |
Evaluating quality-of-life and health status instruments: development of scientific review criteria
|
Lohr, Kathleen N. |
|
1996 |
18 |
5 |
p. 979-992 14 p. |
artikel |
11 |
Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube
|
Chun, Alexander H.C. |
|
1996 |
18 |
5 |
p. 833-842 10 p. |
artikel |
12 |
Pharmaceutical economics & health policy
|
Sclar, DavidAlexander |
|
1996 |
18 |
5 |
p. 876- 1 p. |
artikel |
13 |
Piroxicam fast-dissolving dosage form in the treatment of patients with acute low back pain
|
Englert, Rudolf |
|
1996 |
18 |
5 |
p. 843-852 10 p. |
artikel |
14 |
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
|
Oparil, Suzanne |
|
1996 |
18 |
5 |
p. 797-810 14 p. |
artikel |
15 |
The future of pharmacoeconomics: bridging science and practice
|
Drummond, Michael F. |
|
1996 |
18 |
5 |
p. 969-978 10 p. |
artikel |
16 |
The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study
|
Heinonen, Therese M. |
|
1996 |
18 |
5 |
p. 853-863 11 p. |
artikel |
17 |
The relative community burden of otitis media and varicella
|
Yawn, Barbara P. |
|
1996 |
18 |
5 |
p. 877-886 10 p. |
artikel |
18 |
Usefulness of low-dose, once-daily quinapril as monotherapy for patients with hypertension
|
Olvera, Sergio |
|
1996 |
18 |
5 |
p. 864-873 10 p. |
artikel |